This page contains a Flash digital edition of a book.
COMPANY PROFILE Contact details


Koenigsberger strasse 1 27243 Harpstedt Germany


3S PHARMA


Tel.: +49 4244 95083 www.3spharma.eu


3S-Pharmacological Consultation & Research is a Contract Research Organisation providing complete range of clinical development and bio-analytical services. The Company Headquarter is in Harpstedt, Germany.


The Clinical Research Centers, located in Romania (Dedicated Phase I-IV unit) and Moldavia, were inspected by different European Authorities (French, German, Austrian, Romanian, Danish, etc.); Moldavia also by FDA (no 483 Form). The bio-analytical services are offered by our LC-MS laboratory located in Bucharest, Romania (Pharma Serv International) which is GLP certified since 2003! The bio-analytical laboratory has been repeatedly inspected by French, German, Austrian, Danish, Romanian, Netherland, Austrian authorities and FDA (no 483 Form).


Contact details


1324 Alturas Drive Moscow ID 83843 USA ahoffman@alturasanalytics. com


ALTURAS ANALYTICS, INC.


Tel.: +1 208 883 3400 www.alturasanalytics.com


We deliver results on time with the highest level of integrity. Our business is built on developing long term collaborations with our clients by providing advanced MS/MS solutions.


Alturas has a proven record with complex analyses supporting drug candidates for the pharmaceutical and biotechnology industries, from discovery through phase IV clinical trials. The company operates in a GLP environment using validated operational processes in strict adherence to internal SOPs and applicable global regulations. Bioanalytical services routinely performed include the following: • GC-MS/MS & LC-MS/MS bioanalysis – allows for the broadest range of chemical properties across a wide mass range • GLP and non-GLP bioanalysis in any matrix • Quantitative Antibody Drug Conjugates (ADC) analysis • Biomarker quantitation and Protein binding estimations • Dried Blood (DBS) and Matrix Spot (DMS) analysis (limited sample volume ex. pediatrics, CSF, tears)


Ensuring that a project is completed on time to a company’s specifications demands clear lines of communication be- fore, during and after a study’s completion. An Alturas Study Director is assigned to each client based on their working knowledge with compounds of similar chemical properties. The Study Director: • Is responsible for all technical aspects of the study • Understands the needs of each client timeline • Interacts directly with sponsors pre-study for consultation and project planning • Communicates openly during method development through conduct of the study and final reporting


Alturas is a privately owned company, and greatly enjoys the freedom this provides to focus on fostering strong and lasting relationships with our sponsors while retaining the flexibility needed to accommodate their unique needs.


141


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154